Alerts will be sent to your verified email
Verify EmailAMBALALSA
|
Ambalal Sarabhai Ent
|
Balaxi Pharma.
|
Panchsheel Organics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
0.01 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
19.11 % | 27.3 % | 13.3 % |
|
5yr average Equity Multiplier
|
2.07 | 1.4 | 1.38 |
|
5yr Average Asset Turnover Ratio
|
0.75 | 1.43 | 0.78 |
|
5yr Avg Net Profit Margin
|
10.89 % | 11.03 % | 12.43 % |
|
Price to Book
|
1.6 | 0.87 | 1.4 |
|
P/E
|
24.49 | 14.25 | 13.98 |
|
5yr Avg Cash Conversion Cycle
|
-37.53 Days | 154.28 Days | 170.03 Days |
|
Inventory Days
|
33.51 Days | 87.41 Days | 123.02 Days |
|
Days Receivable
|
63.69 Days | 103.86 Days | 126.46 Days |
|
Days Payable
|
147.98 Days | 63.18 Days | 112.93 Days |
|
5yr Average Interest Coverage Ratio
|
9.88 | 57.05 | 43.42 |
|
5yr Avg ROCE
|
24.01 % | 36.52 % | 17.97 % |
|
5yr Avg Operating Profit Margin
|
5.29 % | 16.64 % | 17.91 % |
|
5 yr average Debt to Equity
|
0.32 | 0.09 | 0.07 |
|
5yr CAGR Net Profit
|
-30.01 % | -5.76 % | 22.45 % |
|
5yr Average Return on Assets
|
8.69 % | 18.47 % | 9.61 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.35 % | 65.99 % | 56.12 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.59 % | -6.87 % | -1.96 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ambalal Sarabhai Ent
|
Balaxi Pharma.
|
Panchsheel Organics
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Capex
|
Capex
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|